Nucleic Acids Research Advance Access originally published online on August 1, 2007
Nucleic Acids Research 2007 35(15):5182-5191; doi:10.1093/nar/gkm478
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Nucleic Acids Research, 2007, Vol. 35, No. 15 5182-5191
© 2007 The Author(s)
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/2.0/uk/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Molecular Biology |
Cell-penetrating peptides as transporters for morpholino oligomers: effects of amino acid composition on intracellular delivery and cytotoxicity
AVI BioPharma, Inc., Corvallis, OR 97333, USA
*To whom correspondence should be addressed. Tel: +1-541-753-3635; Fax: +1-541-754-3545; Email: moulton{at}avibio.com
Received March 13, 2007. Revised May 30, 2007. Accepted May 31, 2007.
Arginine-rich cell-penetrating peptides (CPPs) are promising transporters for intracellular delivery of antisense morpholino oligomers (PMO). Here, we determined the effect of L-arginine, D-arginine and non-
amino acids on cellular uptake, splice-correction activity, cellular toxicity and serum binding for 24 CPP–PMOs. Insertion of 6-aminohexanoic acid (X) or ß-alanine (B) residues into oligoarginine R8 decreased the cellular uptake but increased the splice-correction activity of the resulting compound, with a greater increase for the sequences containing more X residues. Cellular toxicity was not observed for any of the conjugates up to 10 µM. Up to 60 µM, only the conjugates with 
5 Xs exhibited time- and concentration-dependent toxicity. Substitution of L-arginine with D-arginine did not increase uptake or splice-correction activity. High concentration of serum significantly decreased the uptake and splice-correction activity of oligoarginine conjugates, but had much less effect on the conjugates containing X or B. In summary, incorporation of X/B into oligoarginine enhanced the antisense activity and serum-binding profile of CPP–PMO. Toxicity of X/B-containing conjugates was affected by the number of Xs, treatment time and concentration. More active, stable and less toxic CPPs can be designed by optimizing the position and number of R, D-R, X and B residues.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  H. Yin, H. M. Moulton, C. Betts, Y. Seow, J. Boutilier, P. L. Iverson, and M. J.A. Wood A fusion peptide directs enhanced systemic dystrophin exon skipping and functional restoration in dystrophin-deficient mdx mice Hum. Mol. Genet., November 15, 2009; 18(22): 4405 - 4414. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Jearawiriyapaisarn, H. M. Moulton, P. Sazani, R. Kole, and M. S. Willis Long-term improvement in mdx cardiomyopathy after therapy with peptide-conjugated morpholino oligomers Cardiovasc Res, November 3, 2009; (2009) cvp335v2. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. M. Mitev, B. L. Mellbye, P. L. Iversen, and B. L. Geller Inhibition of Intracellular Growth of Salmonella enterica Serovar Typhimurium in Tissue Culture by Antisense Peptide-Phosphorodiamidate Morpholino Oligomer Antimicrob. Agents Chemother., September 1, 2009; 53(9): 3700 - 3704. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. L. Swenson, K. L. Warfield, T. K. Warren, C. Lovejoy, J. N. Hassinger, G. Ruthel, R. E. Blouch, H. M. Moulton, D. D. Weller, P. L. Iversen, et al. Chemical Modifications of Antisense Morpholino Oligomers Enhance Their Efficacy against Ebola Virus Infection Antimicrob. Agents Chemother., May 1, 2009; 53(5): 2089 - 2099. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. L. Mellbye, S. E. Puckett, L. D. Tilley, P. L. Iversen, and B. L. Geller Variations in Amino Acid Composition of Antisense Peptide-Phosphorodiamidate Morpholino Oligomer Affect Potency against Escherichia coli In Vitro and In Vivo Antimicrob. Agents Chemother., February 1, 2009; 53(2): 525 - 530. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Yin, H. M. Moulton, Y. Seow, C. Boyd, J. Boutilier, P. Iverson, and M. J.A. Wood Cell-penetrating peptide-conjugated antisense oligonucleotides restore systemic muscle and cardiac dystrophin expression and function Hum. Mol. Genet., December 15, 2008; 17(24): 3909 - 3918. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Abes, H. M. Moulton, P. Clair, S.-T. Yang, S. Abes, K. Melikov, P. Prevot, D. S. Youngblood, P. L. Iversen, L. V. Chernomordik, et al. Delivery of steric block morpholino oligomers by (R-X-R)4 peptides: structure-activity studies Nucleic Acids Res., November 1, 2008; 36(20): 6343 - 6354. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Wu, H. M. Moulton, P. L. Iversen, J. Jiang, J. Li, J. Li, C. F. Spurney, A. Sali, A. D. Guerron, K. Nagaraju, et al. Effective rescue of dystrophin improves cardiac function in dystrophin-deficient mice by a modified morpholino oligomer PNAS, September 30, 2008; 105(39): 14814 - 14819. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Yang, D. Luo, S. Wang, R. Wang, R. Chen, Y. Liu, T. Zhu, X. Ma, R. Liu, G. Xu, et al. TMTP1, a Novel Tumor-Homing Peptide Specifically Targeting Metastasis Clin. Cancer Res., September 1, 2008; 14(17): 5494 - 5502. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Shiraishi, R. Hamzavi, and P. E. Nielsen Subnanomolar antisense activity of phosphonate-peptide nucleic acid (PNA) conjugates delivered by cationic lipids to HeLa cells Nucleic Acids Res., August 1, 2008; 36(13): 4424 - 4432. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Juliano, Md. R. Alam, V. Dixit, and H. Kang Mechanisms and strategies for effective delivery of antisense and siRNA oligonucleotides Nucleic Acids Res., July 1, 2008; 36(12): 4158 - 4171. [Abstract] [Full Text] [PDF]
|
|